Ing-Ras
Targeted peptide RAS-GTPase inhibitor · publications
- Long-term outcomes of the Ing-Ras trial in advanced gastric and colon tumors Kulinich TM et al. · Bull RSMU 2026;(5) · clinical
-
Development, preclinical and clinical studies of a targeted peptide RAS-GTPase inhibitor for the treatment of malignant tumors Kulinich TM · dissertation, RNCRR 2026 · 294 p. · in Russian
- Results of a phase IIa trial of Ing-Ras in gastrointestinal tumors Kulinich TM et al. · Bull RSMU 2025;(6):36–43 · phase IIa
- Antitumor effectiveness of Inh-Ras in a xenograft model of non-small cell lung cancer Kulinich TM et al. · Adv Mol Oncol 2025;12(1):61–66 · preclinical
- Safety and maximum tolerated dose of iRAS in gastrointestinal tumors: phase I preliminary results Bozhenko VK et al. · Almanac Clin Med 2023;51(7):376–396 · phase I
- Pharmacokinetics of the Ras GTPase peptide inhibitor Inh-Ras Bozhenko VK et al. · Vestnik RNCRR 2023;(4):9–22 · EDN REPWFZ